TB-500 is the synthetic version researchers actually work with. Here’s what three decades of published data show.
This compound is supplied exclusively for in vitro and preclinical research. It is not intended for human consumption, therapeutic application, or diagnostic use.
First, the Biology: What Thymosin Beta-4 Actually Does
Thymosin beta-4 (Tβ4) is a 43-amino-acid peptide found in almost every nucleated cell type, with especially high concentrations in platelets, wound fluid, and developing tissues. Its primary intracellular job: regulating how cells build their structural scaffolding.
The Active Fragment: Ac-SDKP
What the Research Shows
Cardiac Repair
The cardiac research is what really put Tβ4 on the map in regenerative medicine. Bock-Marquette et al. (2004) published a landmark paper in Nature showing that Tβ4 improved survival and cardiac function in a mouse model of myocardial infarction when administered after coronary artery ligation. The proposed mechanisms included:
- Activation of Akt (protein kinase B) survival signaling → reduced cardiomyocyte death
- Promotion of angiogenesis in ischemic tissue → improved blood supply to damaged heart
- Recruitment of cardiac progenitor cells → potential for actual tissue regeneration
Smart et al. (2011) followed up in Nature with evidence that Tβ4 could “prime” epicardial progenitor cells to differentiate into new cardiomyocytes — suggesting regenerative potential beyond simply protecting existing cells from death.
Neurological Protection
Tβ4 research extends into the nervous system. Morris et al. (2010) studied Tβ4 in a traumatic brain injury (TBI) model and found improved functional outcomes, reduced inflammation, increased angiogenesis, and enhanced neurogenesis in the hippocampus. Xiong et al. (2012) reported similar findings in a stroke model, with Tβ4 treatment improving neurological function scores and increasing oligodendrocyte progenitor cells — the cells responsible for myelination (insulating nerve fibers).
TB-500 vs Thymosin Beta-4: What Researchers Should Know
TB-500 is a synthetic peptide corresponding to the active region of thymosin beta-4 — specifically the region containing the actin-binding domain (amino acids 17-23: LKKTETQ). It’s not identical to full-length Tβ4 but includes the key functional sequence responsible for the cell migration, angiogenesis, and wound-healing properties observed in Tβ4 research.
Researchers use TB-500 rather than full-length Tβ4 for practical reasons: it’s easier and cheaper to synthesize, more stable, and contains the biologically active sequence. Most of the published literature uses full-length Tβ4, but the overlapping active region means TB-500 research findings are generally interpreted in the context of the broader Tβ4 literature.
The BPC-157 + TB-500 Question
Product Specifications
- Active Sequence: Contains LKKTETQ actin-binding domain
- Molecular Weight: ~4,963 g/mol
- CAS Number: 77591-33-4 (Thymosin Beta-4)
- Physical Form: Sterile lyophilized white powder
- Purity: ≥99% (verified by HPLC)
Key References
- Bock-Marquette I, et al. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432:466-472.
- Smart N, et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature. 2011;474:640-644.
- Morris DC, et al. Thymosin β4 improves functional neurological outcome in a rat model of TBI. Neuroscience. 2010;169:674-682.